929 related articles for article (PubMed ID: 8930526)
1. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
3. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.
Kleiber H; Rey F; Temler E; Gomez F
J Endocrinol Invest; 1991 Jun; 14(6):489-92. PubMed ID: 1663528
[TBL] [Abstract][Full Text] [Related]
4. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
5. Serum dehydroepiandrosterone sulfate in Cushing's syndrome.
Yamaji T; Ishibashi M; Sekihara H; Itabashi A; Yanaihara T
J Clin Endocrinol Metab; 1984 Dec; 59(6):1164-8. PubMed ID: 6238041
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
8. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
Midorikawa S; Sanada H; Hashimoto S; Suzuki T; Watanabe T; Sasano H
Endocr J; 2001 Apr; 48(2):167-74. PubMed ID: 11456263
[TBL] [Abstract][Full Text] [Related]
9. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
[TBL] [Abstract][Full Text] [Related]
10. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
[TBL] [Abstract][Full Text] [Related]
11. Subclinical Cushing's syndrome.
Reincke M
Endocrinol Metab Clin North Am; 2000 Mar; 29(1):43-56. PubMed ID: 10732263
[TBL] [Abstract][Full Text] [Related]
12. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
13. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between plasma adrenal androgens and cortisol in Cushing's disease and ectopic ACTH-producing tumour: relation to adrenarche.
Hauffa BP; Kaplan SL; Grumbach MM
Lancet; 1984 Jun; 1(8391):1373-6. PubMed ID: 6145833
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
16. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas).
Osella G; Terzolo M; Borretta G; Magro G; Alí A; Piovesan A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1994 Dec; 79(6):1532-9. PubMed ID: 7989452
[TBL] [Abstract][Full Text] [Related]
17. Adrenal reserve function after unilateral adrenalectomy in patients with primary aldosteronism.
Honda K; Sone M; Tamura N; Sonoyama T; Taura D; Kojima K; Fukuda Y; Tanaka S; Yasuno S; Fujii T; Kinoshita H; Ariyasu H; Kanamoto N; Miura M; Yasoda A; Arai H; Ueshima K; Nakao K
J Hypertens; 2013 Oct; 31(10):2010-7. PubMed ID: 23846863
[TBL] [Abstract][Full Text] [Related]
18. Plasma testosterone profiles in Cushing's syndrome.
Smals AG; Kloppenborg PW; Benraad TJ
J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
[TBL] [Abstract][Full Text] [Related]
19. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
[TBL] [Abstract][Full Text] [Related]
20. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
